1. Protocol violation: detection of eligibility violations, poor compliance (mean compliance < 70% at the last estimation) or noncompliance, use of any forbidden medication or treatment during the trial that could affect the study results, occurrence of other significant protocol violation during the trial |
2. Occurrence of a serious adverse event |
3. Subject has an acute reaction (allergy, shock and so on) to the investigational product |
4. Detection of a systemic disease that was not discovered at the screening stage |
5. Unable to progress because of worsening of preexisting disease |
6. Subject's withdrawal of consent |
7. Subject is uncooperative |
8. Investigator's decision to terminate the process for the sake of the subject's health |